Equine platelets inhibit E. coli growth and can be activated by bacterial lipopolysaccharide and lipoteichoic acid although superoxide anion production does not occur and platelet activation is not associated with enhanced production by neutrophils

Veterinary Immunology and Immunopathology

Volumn 152, Issue 3-4, 2013, Pages 209-217

  Aktan, I ^a   Dunkel, B ^a   Cunningham, F M ^a  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

Author keywords

Bacterial growth; Equine platelets; Lipoteichoic acid; LPS; P selectin; Superoxide

Indexed keywords

ESCHERICHIA COLI LIPOPOLYSACCHARIDE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; LIPOTEICHOIC ACID; PADGEM PROTEIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; SUPEROXIDE; THROMBIN; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; CENTRIFUGATION; CONTROLLED STUDY; ESCHERICHIA COLI; HORSE; IN VITRO STUDY; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; STAPHYLOCOCCUS AUREUS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE POOR PLASMA; THROMBOCYTE RICH PLASMA;

ANIMALS; BLOOD PLATELETS; CELL AGGREGATION; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HORSE DISEASES; HORSES; HOST-PATHOGEN INTERACTIONS; LIPOPOLYSACCHARIDES; NEUTROPHILS; P-SELECTIN; PLATELET ACTIVATION; SUPEROXIDES; TEICHOIC ACIDS;

BACTERIA (MICROORGANISMS); EQUIDAE; ESCHERICHIA COLI; STAPHYLOCOCCUS AUREUS;

EID: 84875505113     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2012.12.007     Document Type: Article

References (44)

1. Aktan I., Dunkel B., Cunningham F.M. PKC isoenzymes in equine platelets and stimulus induced activation. Vet. Immunol. Immunopathol. 2011, 141:276-282.
2. Bailey S.R., Adair H.S., Reinemeyer C.R., Morgan S.J., Brooks A.C., Longhofer S.L., Elliott J. Plasma concentrations of endotoxin and platelet activation in the developmental stage of oligofructose-induced laminitis. Vet. Immunol. Immunopathol. 2009, 129:167-173.
3. Bengtsson T., Zalavary S., Stendahl O., Grenegård M. Release of oxygen metabolites from chemoattractant-stimulated neutrophils is inhibited by resting platelets: role of extraellular adenosine and actin polymerisation. Blood 1996, 10:4411-4423.
4. Brazil T.J., Rossi A.G., Haslett C., McGorum B., Dixon P.M., Chilvers E.R. Priming induces functional coupling of N-formyl-methionyl-leucyl-phenylalanine receptors in equine neutrophils. J. Leukoc. Biol. 1998, 63:380-388.
5. Brooks A.C., Menzies-Gow N.J., Wheeler-Jones C., Bailey S.R., Cunningham F.M., Elliott J. Endotoxin-induced activation of equine platelets: evidence for direct activation of p38 MAPK pathways and vasoactive mediator production. Inflamm. Res. 2007, 56:154-161.
6. Brooks A.C., Menzies-Gow N.J., Wheeler-Jones C.P., Bailey S.R., Elliott J., Cunningham F.M. Regulation of platelet activating factor-induced equine platelet activation by intracellular kinases. J. Vet. Pharmacol. Ther. 2009, 32:189-196.
7. Burnouf T., Chou M.-L., Wu Y.-W., Lee L.-W. Antimicrobial activity of platelet (PLT)-poor plasma, PLT-rich plasma, PLT gel, and solvent/detergent-treated PLT lysate biomaterials against wound bacteria. Transfusion 2012, (May). [Epub ahead of print]. 10.1111/j.1537-2995.2012.03668.x.
8. Cognasse F., Hamzeh H., Chavarin P., Acquart S., Genin C., Garraud O. Evidence of toll-like receptor molecules on human platelets. Immunol. Cell Biol. 2005, 83:196-198.
9. Czapiga M., Gao J.L., Kirk A., Lekstrom-Himes J. Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp. Hematol. 2005, 33:73-84.
10. Dunkel B., Rickards K.J., Page C.P., Cunningham F.M. Platelet activation in ponies with airway inflammation. Equine Vet. J. 2007, 39:557-561.
11. Dunkel B., Rickards K.J., Werling D., Page C.P., Cunningham F.M. Neutrophil and platelet activation in equine recurrent airway obstruction is associated with increased neutrophil CD13 expression, but not platelet CD41/61 and CD62P or neutrophil-platelet aggregate formation. Vet. Immunol. Immunopathol. 2009, 131:25-32.
12. Evangelista V., Manarini S., Totondo S., Martelli N., Polischuk R., McGregor J.L., de Gaetano G., Cerletti C. Platelet/polymorphonuclear leukocyte interactions in dynamic conditions: evidence of adhesion cascade and cross talk between P-selectin and the β2 integrin CD11b/CD18. Blood 1996, 88:4183-4194.
13. Foster A.P., Cunningham F.M. Differential superoxide anion generation by equine eosinophils and neutrophils. Vet. Immunol. Immunopathol. 1997, 59:225-237.
14. Foster A.P., Lees P., Andrews M.J., Cunningham F.M. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse. Equine Vet. J. 1992, 24:203-207.
15. Krötz F., Sohn H.Y., Gloe T., Zahler S., Riexinger T., Schiele T.M., Becker B.F., Theisen K., Klauss V., Pohl U. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 2002, 100:917-924.
16. Lalko C.C., Deppe E., Ulatowski D., Lutgen A., Hart A.P., Patton E.A., Lunn D.P., Suresh M., Darien B.J. Equine platelet CD62P (P-selectin) expression: a phenotypic and morphologic study. Vet. Immunol. Immunopathol. 2003, 91:119-134.
17. LeBlanc M.M., Causey R.C. Clinical and subclinical endometritis in the mare: both threats to fertility. Reprod. Domest. Anim. 2009, 44(Suppl. 3):10-22.
18. Levy O. Antimicrobial proteins and peptides of blood: templates for novel antimicrobial agents. Blood 2000, 96:2664-2672.
19. Marcus A.J., Silk S.T., Safier L.B., Ullman H.L. Superoxide production and reducing activity in human platelets. J. Clin. Invest. 1977, 59:149-158.
20. Menzies-Gow N.J., Bailey S.R., Katz L.M., Marr C.M., Elliott J. Endotoxin-induced digital vasoconstriction in horses: associated changes in plasma concentrations of vasoconstrictor mediators. Equine Vet. J. 2004, 36:273-278.
21. Menzies-Gow N.J., Sepulveda M.F., Bailey S.R., Cunningham F.M., Elliott J. Roles of thromboxane A2 and 5-hydroxytryptamine in endotoxin-induced digital vasoconstriction in horses. Am. J. Vet. Res. 2008, 69:199-207.
22. Mercier R.-C., Rykak M.J., Bayer A.S., Yeaman M.R. Influence of platelets and platelet microbicidal protein susceptibility on the fate of Staphylococcus aureus in an in vitro model of infective endocarditis. Infect. Immun. 2000, 68:4699-4705.
23. Miles A.A., Misra S.S. The estimation of the bactericidal power of blood. J. Hyg. 1938, 38:732-749.
24. Murphy C.T., Westwick J. Selective inhibition of protein kinase C: effect on platelet-activating-factor-induced platelet functional responses. Biochem. J. 1992, 283:159-164.
25. Nagata K., Tsuji T., Todoroki N., Katagiri Y., Tanoue K., Yamazaki H., Hanai N., Irimura T. Activated platelets induce superoxide anion release by monocytes and neutrophils through P-selectin (CD62). J. Immunol. 1993, 151:3267-3273.
26. Peters M.J., Dixon G., Kotowicz K.T., Hatch D.J., Heyderman R.S., Klein N.J. Circulating platelet-neutrophil complexes represent a subpopulation of activated neutrophils primed for adhesion, phagocytosis and intracellular killing. Br. J. Haematol. 1999, 106:391-399.
27. Segura D., Monreal L., Pérez-Pujol S., Pino M., Ordinas A., Brugués R., White J.G., Escolar G. Assessment of platelet function in horses: ultrastructure, flow cytometry, and perfusion techniques. J. Vet. Intern. Med. 2006, 20:581-588.
28. Sheu J.-R., Hsaio G., Lee C.-R., Chang W.-C., Lee L.-W., Su C.-H., Lin C.-H. Antiplatelet activity of Staphylococcus aureus lipoteichoic acid is mediated through a cyclic AMP pathway. Thromb. Res. 2000, 99:249-258.
29. Ståhl A.-I., Sartz L., Nelsson A., Békássy S.D., Karpman D. Shiga toxin and lipopolysaccharide induce platelet-leucocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS One 2009, 4:e6990.
30. Tang Y.-Q., Yeaman M.R., Selsted M.E. Antimicrobial peptides from human platelets. Infect. Immun. 2002, 70:6524-6533.
31. Tsuji T., Nagata K., Koike J., Todoroki N., Irimura T. Induction of superoxide anion production from monocytes and neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction. J. Leukoc. Biol. 1994, 56:583-587.
32. Wachowicz B., Saluk J., Kaca W. Response of blood platelets to Proteus mirabilis lipopolysaccharide. Microbiol. Immunol. 1998, 42:47-49.
33. Weiss D.J., Evanson O.A., McClenahan D., Fagliari J., Walcheck B. Shear-induced platelet activation and platelet-neutrophil aggregate formation by equine platelets. Am. J. Vet. Res. 1998, 59:1243-1246.
34. Werners A.H., Bull S., Fink-Gremmels J. Endotoxaemia: a review with implications for the horse. Equine Vet. J. 2005, 37:371-383.
35. Wiesner J., Vilcinskas A. Antimicrobial peptides: the ancient arm of the human immune system. Virulence 2010, 1:440-464.
36. Wong C.S., Gamble J.R., Skinner M.P., Lucas C.M., Berndt M.C., Vadas M.A. Induction of superoxide anion production from monocytes and neutrophils by activated platelets through the P-selectin-sialyl Lewis X interaction. J. Leukoc. Biol. 1994, 56:583-587.
37. Wu B.Q., Zhi M.J., Liu H., Huang J., Zhou Y.Q., Zhang T.T. Inhibitory effects of lipoteichoic acid from Staphylococcus aureus on platelet function and platelet-monocyte aggregation. Inflamm. Res. 2011, 60:775-782.
38. Yeaman M.R. Platelets in defense against bacterial pathogens. Cell. Mol. Life Sci. 2010, 67:525-544.
39. Youssefian T., Drouiin A., Massé J.-M., Guichard J., Cramer E.M. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood 2002, 99:4021-4029.
40. Zalavary S., Grenegard M., Stendahl O., Bengtsson T. Platelets enhance Fcγ receptor-mediated phagocytosis and respiratory burst in neutrophils: the role of purinergic modulation and actin polymerisation. J. Leukoc. Biol. 1996, 60:58-68.
41. Zander D.M., Klinger M. The blood platelets contribute to innate host defense - what have they learned from their big brothers. Biotechnol. J. 2009, 4:914-926.
42. Zhang Q., Mousidicas N., Yi Q., Al-Hassani M., Billings S.D., Perkins S.M., Howard K.M., Ishii S., Shimizu T., Travers J.B. Staphyloccoccal lipoteichoic acid inhibits delayed-type hypersensitivity reactions via the platelet-activating factor receptor. J. Clin. Invest. 2005, 115:2855-2861.
43. Zhang G., Han J., Welch E.J., Ye R.D., Voyno-Yasenetskaya T.A., Malik A.B., Du X., Li Z. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J. Immunol. 2009, 182:7997-8004.
44. Zielinski T., Wachowicz B., Saluk-Juszczak J., Kaca W. The generation of superoxide anion in blood platelets in response to different forms of Proteus mirabilis lipopolysaccharide: effects of staurosporin, wortmannin, and indomethacin. Thromb. Res. 2001, 103:149-215.